504 related articles for article (PubMed ID: 22198801)
21. [Acetylcholinesterase inhibitors for treatment of Alzheimer's disease].
Shinagawa S; Shigeta M
Brain Nerve; 2014 May; 66(5):507-16. PubMed ID: 24807367
[TBL] [Abstract][Full Text] [Related]
22. The costs of Alzheimer's disease and the value of effective therapies.
Stefanacci RG
Am J Manag Care; 2011 Nov; 17 Suppl 13():S356-62. PubMed ID: 22214393
[TBL] [Abstract][Full Text] [Related]
23. Potential therapeutic agents against Alzheimer's disease from natural sources.
Park SY
Arch Pharm Res; 2010 Oct; 33(10):1589-609. PubMed ID: 21052936
[TBL] [Abstract][Full Text] [Related]
24. [Intended pharmacotherapeutical approaches of Alzheimer's disease therapy].
Korábecný J; Hrubá E; Soukup O; Zemek F; Musílek K; Nepovímová E; Spilovská K; Opletalová V; Kuca K
Ceska Slov Farm; 2012 Feb; 61(1-2):4-10. PubMed ID: 22536646
[TBL] [Abstract][Full Text] [Related]
25. Outcomes of Alzheimer's disease therapy with acetylcholinesterase inhibitors and memantine.
Zemek F; Drtinova L; Nepovimova E; Sepsova V; Korabecny J; Klimes J; Kuca K
Expert Opin Drug Saf; 2014 Jun; 13(6):759-74. PubMed ID: 24845946
[TBL] [Abstract][Full Text] [Related]
26. [Treatment of Alzheimer's Disease cognitive symptoms].
Abel C; Allegri RF; Garau L; Genovese O; Mangone CA
Vertex; 2008; 19 Suppl():39-47. PubMed ID: 18392212
[TBL] [Abstract][Full Text] [Related]
27. A review on Alzheimer's disease pathophysiology and its management: an update.
Kumar A; Singh A; Ekavali
Pharmacol Rep; 2015 Apr; 67(2):195-203. PubMed ID: 25712639
[TBL] [Abstract][Full Text] [Related]
28. Recommendations for best practices in the treatment of Alzheimer's disease in managed care.
Fillit HM; Doody RS; Binaso K; Crooks GM; Ferris SH; Farlow MR; Leifer B; Mills C; Minkoff N; Orland B; Reichman WE; Salloway S
Am J Geriatr Pharmacother; 2006; 4 Suppl A():S9-S24; quiz S25-S28. PubMed ID: 17157793
[TBL] [Abstract][Full Text] [Related]
29. Alzheimer's disease: beware of interactions with cholinesterase inhibitors.
Prescrire Int; 2006 Jun; 15(83):103-6. PubMed ID: 16764099
[TBL] [Abstract][Full Text] [Related]
30. Treatment strategies for the behavioral symptoms of Alzheimer's disease: focus on early pharmacologic intervention.
Beier MT
Pharmacotherapy; 2007 Mar; 27(3):399-411. PubMed ID: 17316151
[TBL] [Abstract][Full Text] [Related]
31. Contemporary issues in the treatment of Alzheimer's disease: tangible benefits of current therapies.
Tariot PN
J Clin Psychiatry; 2006; 67 Suppl 3():15-22; quiz 23. PubMed ID: 16649847
[TBL] [Abstract][Full Text] [Related]
32. Alzheimer's dementia: current data review.
Uzun S; Kozumplik O; Folnegović-Smalc V
Coll Antropol; 2011 Dec; 35(4):1333-7. PubMed ID: 22397284
[TBL] [Abstract][Full Text] [Related]
33. Symptomatic and Disease-Modifying Therapy Pipeline for Alzheimer's Disease: Towards a Personalized Polypharmacology Patient-Centered Approach.
Morató X; Pytel V; Jofresa S; Ruiz A; Boada M
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012569
[TBL] [Abstract][Full Text] [Related]
34. Elucidating Treatment of Alzheimer's Disease via Different Receptors.
Ul Islam B; Khan MS; Jabir NR; Kamal MA; Tabrez S
Curr Top Med Chem; 2017; 17(12):1400-1407. PubMed ID: 28049400
[TBL] [Abstract][Full Text] [Related]
35. What is the rationale for new treatment strategies in Alzheimer's disease?
Rogawski MA
CNS Spectr; 2004 Jul; 9(7 Suppl 5):6-12. PubMed ID: 15241294
[TBL] [Abstract][Full Text] [Related]
36. Alzheimer's disease: Molecular aspects and treatment opportunities using herbal drugs.
Thakral S; Yadav A; Singh V; Kumar M; Kumar P; Narang R; Sudhakar K; Verma A; Khalilullah H; Jaremko M; Emwas AH
Ageing Res Rev; 2023 Jul; 88():101960. PubMed ID: 37224884
[TBL] [Abstract][Full Text] [Related]
37. Pharmacologists and Alzheimer disease therapy: to boldly go where no scientist has gone before.
Mancuso C; Siciliano R; Barone E; Butterfield DA; Preziosi P
Expert Opin Investig Drugs; 2011 Sep; 20(9):1243-61. PubMed ID: 21810032
[TBL] [Abstract][Full Text] [Related]
38. Current pharmacotherapy for Alzheimer's disease.
Lleó A; Greenberg SM; Growdon JH
Annu Rev Med; 2006; 57():513-33. PubMed ID: 16409164
[TBL] [Abstract][Full Text] [Related]
39. Beyond immunotherapy: new approaches for disease modifying treatments for early Alzheimer's disease.
Ruthirakuhan M; Herrmann N; Suridjan I; Abraham EH; Farber I; Lanctôt KL
Expert Opin Pharmacother; 2016 Dec; 17(18):2417-2429. PubMed ID: 27825018
[TBL] [Abstract][Full Text] [Related]
40. Effects of acetylcholinesterase inhibitors and memantine on resting-state electroencephalographic rhythms in Alzheimer's disease patients.
Babiloni C; Del Percio C; Bordet R; Bourriez JL; Bentivoglio M; Payoux P; Derambure P; Dix S; Infarinato F; Lizio R; Triggiani AI; Richardson JC; Rossini PM
Clin Neurophysiol; 2013 May; 124(5):837-50. PubMed ID: 23098644
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
